Trial Profile
Pharmacokinetics and Safety of MNK-155 in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 07 Apr 2017
Price :
$35
*
At a glance
- Drugs Hydrocodone/paracetamol (Primary)
- Indications Postoperative pain
- Focus Pharmacokinetics
- Sponsors Mallinckrodt Inc.
- 06 Nov 2016 Status changed from recruiting to withdrawn prior to enrolment.
- 13 May 2016 New trial record